The P2Y 2 receptor is a uridine/adenosine triphosphate (UTP/ ATP)-sensitive G-protein-linked nucleotide receptor that previously has been reported to stimulate the phosphoinositide signaling pathway. Messenger RNA for this receptor has been detected in brain tissue. We have investigated the coupling of the molecularly defined rat P2Y 2 receptor to neuronal N-type Ca 2ϩ channels and to M-type K ϩ channels by heterologous expression in rat superior cervical sympathetic (SCG) neurons. After the injection of P2Y 2 cRNA, UTP inhibited the currents carried by both types of ion channel. As previously reported [Filippov AK, Webb TE, Barnard EA, Brown DA (1997) Inhibition by heterologously expressed P2Y 2 nucleotide receptors of N-type calcium currents in rat sympathetic neurones. Br J Pharmacol 121:849-851], UTP inhibited the Ca 2ϩ current (I Ca(N) ) by up to 64%, with an IC 50 of ϳ0.5 M. We now find that UTP also inhibited the K ϩ M current (I K(M) ) by up to 61%, with an IC 50 of ϳ1.5 M. UTP had no effect on either current in neurons not injected with P2Y 2 cRNA. Structure-activity relations for the inhibition of I Ca(N) and I K(M) in P2Y 2 cRNA-injected neurons were similar, with UTP Ն ATP Ͼ ITP Ͼ Ͼ GTP,UDP. However, coupling to these two channels involved different G-proteins: pretreatment with Pertussis toxin (PTX) did not affect UTP-induced inhibition of I K(M) but reduced inhibition of I Ca(N) by ϳ60% and abolished the voltage-dependent component of this inhibition. In unclamped neurons, UTP greatly facilitated depolarizationinduced action potential discharges. Thus, the single P2Y 2 receptor can couple to at least two G-proteins to inhibit both Ca 2ϩ N and K ϩ M channels with near-equal facility. This implies that the P2Y 2 receptor may induce a broad range of effector responses in the nervous system.
The P2Y 2 receptor is a uridine/adenosine triphosphate (UTP/ ATP)-sensitive G-protein-linked nucleotide receptor that previously has been reported to stimulate the phosphoinositide signaling pathway. Messenger RNA for this receptor has been detected in brain tissue. We have investigated the coupling of the molecularly defined rat P2Y 2 receptor to neuronal N-type Ca 2ϩ channels and to M-type K ϩ channels by heterologous expression in rat superior cervical sympathetic (SCG) neurons. After the injection of P2Y 2 cRNA, UTP inhibited the currents carried by both types of ion channel. As previously reported [Filippov AK, Webb TE, Barnard EA, Brown DA (1997) Inhibition by heterologously expressed P2Y 2 nucleotide receptors of N-type calcium currents in rat sympathetic neurones. Br J Pharmacol 121:849-851], UTP inhibited the Ca 2ϩ current (I Ca(N) ) by up to 64%, with an IC 50 of ϳ0.5 M. We now find that UTP also inhibited the K ϩ M current (I K(M) ) by up to 61%, with an IC 50 of ϳ1.5 M. UTP had no effect on either current in neurons not injected with P2Y 2 cRNA. Structure-activity relations for the inhibition of I Ca(N) and I K(M) in P2Y 2 cRNA-injected neurons were similar, with UTP Ն ATP Ͼ ITP Ͼ Ͼ GTP,UDP. However, coupling to these two channels involved different G-proteins: pretreatment with Pertussis toxin (PTX) did not affect UTP-induced inhibition of I K(M) but reduced inhibition of I Ca(N) by ϳ60% and abolished the voltage-dependent component of this inhibition. In unclamped neurons, UTP greatly facilitated depolarizationinduced action potential discharges. Thus, the single P2Y 2 receptor can couple to at least two G-proteins to inhibit both Ca 2ϩ N and K ϩ M channels with near-equal facility. This implies that the P2Y 2 receptor may induce a broad range of effector responses in the nervous system.
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Nucleotides such as ATP play a significant neurotransmitter role in the mammalian nervous system (Burnstock, 1972 (Burnstock, , 1990 Edwards and Gibb, 1993; Z immermann, 1994) . There are two families of target nucleotide receptors known at the molecular level-ligand-gated P2X receptors and G-protein-coupled P2Y receptors (North and Barnard, 1997) .
The P2Y 2 receptor is a member of the family of P2Y G-protein-coupled receptors and is sensitive to both ATP and UTP; it was cloned originally from mouse NG108-15 neuroblastoma X glioma hybrid cells (L ustig et al., 1993) . In common with other P2Y receptors (Boarder et al., 1995) , P2Y 2 receptors from different species all couple to the enzyme phospholipase C (PLC), thereby increasing inositol phosphate production and elevating intracellular [C a 2ϩ ] (Erb et al., 1993; L ustig et al., 1993; Parr et al., 1994; Rice et al., 1995; Chen et al., 1996; Nicholas et al., 1996) .
Messenger RNA for the P2Y 2 receptor, which is found in a range of tissues, is also present in the brain (L ustig et al., 1993) , so the question arises as to what effect the activation of this receptor might have on neural f unction. In native NG108-15 cells, UTP inhibits two membrane ionic currents-an M-like K ϩ current ("M-current") and the voltage-gated C a 2ϩ current (Filippov et al., 1994; Filippov and Brown, 1996) . The former was to be expected because other receptors that activate PLC inhibit M-currents (Brown, 1988) , but Ca 2ϩ current inhibition was unexpected, especially because it was mediated (in part, at least) by a different G-protein from that responsible for M-current inhibition (Filippov and Brown, 1996) . This raised the question whether both effects actually were produced by the same receptor as that previously cloned from these cells or whether two different receptors were responsible. If the former, was this a peculiarity of this particular cell line, or would it also hold for primary neurons?
To address these questions, we have expressed the recombinant rat P2Y 2 receptor in primary cultured rat superior cervical sympathetic (SCG) neurons by microinjecting cRNA, in the manner used by Ikeda et al. (1995) to express heterologous "metabotropic" glutamate receptors, and then recording the effects of activating these exogenous receptors with UTP on the N-type Ca 2ϩ currents (I C a(N) ; Hirning et al., 1988; Plummer et al., 1989; Regan et al., 1991) and M-type K ϩ currents (I K(M) ; Constanti and Brown, 1981) that are present in these neurons. In preliminary experiments (Filippov et al., 1997) we found that the activation of these expressed receptors did indeed inhibit I C a(N) . In the present experiments we have analyzed this action in more detail and have gone on to test whether the same single receptor also can inhibit the M-type K ϩ current. We find that it can; the two currents are inhibited by UTP with near-equal potencies and efficacy, although mediated mainly by different G-proteins, and in joint response increase the excitability of these neurons. Thus, the P2Y 2 receptor appears to be unusually promiscuous in terms of its coupling to mammalian neuronal G-proteins and ion channels. This has interesting implications for its potential f unction in nerve cells.
MATERIALS AND METHODS
cR NA preparation. The rat P2Y 2 receptor cDNA was obtained from Dr. Z eng-Ping Chen (Department of Neuroscience and C ell Biology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, NJ). A 2 kb EcoRI-XhoI fragment was cloned into the reciprocal sites of pBK /C M V. The wild-type green fluorescent protein (GFP) cDNA, in pBluescript, also was used. Supercoiled plasmid DNA was prepared from both constructs and linearized with XhoI for P2Y 2 and with EcoRI for GFP before use as a template for cRNA synthesis. C apped cRNA was transcribed with T3 polymerase (Message Machine, Ambion, Austin, TX), and an aliquot of each was analyzed on a denaturing agarose gel to check its integrity before polyadenylation, using poly(A ϩ ) polymerase (Sigma, St. L ouis, MO) according to the manufacturer's recommendations. After extractions in turn with phenol, phenol /chloroform, and chloroform and isopropanol precipitation, the cRNA was stored as an ethanol precipitate at Ϫ70°C before use.
Neuron preparation and cR NA injection. Single SCG neurons were dissociated from rats aged 15-19 d, and plated on poly-D-lysine-coated glass coverslips bordered by 2 cm plastic rings as previously described (Marrion et al., 1987) . At 4 hr after plating, the neurons were microinjected with an equal mixture of cRNA for the P2Y 2 receptor (final pipette concentration of 0.5 or 1.25 g/l dissolved in water) and cRNA for GFP (used as a marker for foreign cRNA expression; Marshall et al., 1995) or, for controls, with GFP cRNA alone. cRNA solution (1.2 l) was loaded into prepulled high-resistance (ϳ30 M⍀) Pyrex glass pipettes and injected manually into single neurons by the application of gentle pressure to the back of the pipette with a syringe as described previously for injection of antisera (C aulfield et al., 1994) . Successf ul injection usually resulted in a ϳ10% increase in cell volume (Ikeda et al., 1995) . After injections, cells were incubated for 14 -24 hr in a humidified incubator (5% C O 2 /95% O 2 ) at 37°C. Injected neurons that successf ully expressed cRNA were identified as bright fluorescent cells, using an inverted microscope (Diaphot 200, Nikon, Tokyo, Japan) equipped with an epifluorescent N B2E block (Nikon). When required, Pertussis toxin (P TX) at a final concentration of 500 ng /ml was added to the culture media 1-2 hr after neuron injection. Electrophysiological recordings were made 14 -24 hr after injection at room temperature (20°C). Some experiments on neuron excitability were made at 34°C. Ca 2ϩ channel current recording. Currents through voltage-gated C a 2ϩ channels were recorded by the conventional whole-cell patch-clamp method as described previously (C aulfield et al., 1994) . C ells were superf used (20 -25 ml /min) with a solution consisting of (in mM) 120 tetraethylammonium chloride, 3 KC l, 1.5 MgC l 2 , 5 BaC l 2 (or 5 C aC l 2 ), 10 H EPES, and 11.1 glucose plus 0.5 M tetrodotoxin. The pH was adjusted to 7.35 with NaOH. Patch electrodes (2-3 M⍀) were filled with a solution containing (in mM) 110 CsCl, 3 Mg Cl 2 , 40 H EPES, 3 EGTA, 2 Na 2 ATP, and 0.5 Na 2 GTP (pH-adjusted to 7.4 with C sOH). Neurons were voltage-clamped with a discontinuous ("switching") amplifier (Axoclamp 2B) with a sampling voltage at 6 -8 kHz (50% duty cycle). Commands were generated via a Digidata 1200 interface, using pC lamp 6 computer software (Axon Instruments, Foster C ity, CA). C a 2ϩ channel currents were evoked routinely every 20 sec with a 100 msec depolarizing rectangular test pulse to 0 mV from a holding potential of Ϫ90 mV. To obtain current-voltage ( I-V) relations, we evoked currents by test pulses in 10 mV increments to ϩ40 mV, starting from the holding potential of Ϫ90 mV. Where required, I-V relations were obtained by using 750 msec ramp depolarizations from Ϫ90 to ϩ 40 mV (see Docherty et al., 1991) . Currents were digitized and stored on a computer for later analysis by pC lamp 6 software (Axon Instruments). C a 2ϩ channel current amplitudes were measured isochronally 10 msec from the onset of the rectangular test pulse (Ikeda et al., 1995) , i.e., near to the peak of the control current. To eliminate leak currents, we substituted Co 2ϩ for C a 2ϩ and Ba 2ϩ in the external solution at the end of each experiment to block all Ca 2ϩ channel currents, and we digitally subtracted the residual current from the corresponding currents in C a 2ϩ or Ba 2ϩ solution.
M-t ype K
ϩ current recordings. Whole-cell M-currents (I K(M) ) were recorded by the perforated patch-clamp method (Horn and Marty, 1988) , as described for the application to SCG neurons by C aulfield et al. (1994) . Briefly, patch pipettes (2-4 M⍀) were filled by dipping the tip into a filtered solution containing (in mM) 90 potassium acetate, 20 KC l, 3 MgC l 2 , 40 H EPES, and 0.1 BAP TA (pH-adjusted to 7.4 by KOH) for 20 -60 sec. Then the pipette was back-filled with the same solution containing 0.125 mg /ml amphotericin B as the permeabilizing agent (Rae et al., 1991) . Access resistance after permeabilization was 8 -15 M⍀. Neurons were superf used (20 -25 ml /min) with external modified Krebs' solution containing (in mM) 120 NaC l, 3 KC l, 1.5 MgC l 2 , 2.5 CaCl 2 , 10 H EPES, and 11.1 glucose (pH-adjusted to 7.3 with NaOH). Neurons were voltage-clamped at Ϫ20 or Ϫ30 mV with a switching amplifier, and M-currents were deactivated with 1 sec hyperpolarizing steps at 5 sec intervals. I-V relationships were obtained by using incremental voltage steps of 10 mV between Ϫ10 and Ϫ100 mV; currents were measured at the end of each hyperpolarizing step. For dose -response curves, currents were measured at Ϫ30 mV from steady-state I-V relations obtained by using a ramp voltage command of 20 sec from Ϫ20 to Ϫ90 mV. The leak component of current was estimated in both cases by extrapolating a linear fit to the I-V relationship from the negative potential region, where only ohmic currents were observed. All commands, current recordings, and analyses were made with Digidata 1200 interface and pC lamp 6 software (Axon Instruments).
Statistical anal ysis. Data are presented as mean Ϯ SEM as appropriate. Student's t test (unpaired) was applied to determine statistical significance. The difference was considered significant if p Յ 0.05. Doseresponse curves were determined by using concentrations that were added cumulatively, with 1 min exposure times. Curves were fit (using Origin 4.1 software) to pooled data points to the Hill equation:
, where y ϭ the observed percentage of inhibition, y max ϭ extrapolated maximal percentage of inhibition, x ϭ nucleotide concentration (M), K ϭ IC 50 (M), and n H ϭ the Hill coefficient.
Chemicals. UTP rather than ATP was used as the main agonist throughout to preclude the activation of ATP-sensitive endogenous P2X ligand-gated channels (C loues et al., 1993) . Drugs were applied to the external solution by bath perf usion (bath exchange rate Յ5 sec). Tetrodotoxin was obtained from C albiochem (La Jolla, CA); uridine 5Ј-triphosphate (UTP) was from Pharmacia Biotech (Uppsala, Sweden) and from Sigma; ATP, inosine 5Ј-triphosphate (I TP), guanosine 5Ј-triphosphate (GTP), acetylcholine chloride, (Ϫ)-norepinephrine bitartrate, nifedipine, BAP TA, and amphotericin B were all from Sigma; adenosine 5Ј-diphosphate (ADP) and uridine 5Ј-diphosphate (UDP) were from Sigma and Boehringer Mannheim GmbH (Mannheim, Germany); hexokinase was from Boehringer Mannheim GmbH; oxotremorine-M (OxoM) was from Research Biochemicals (Natick, M A); Pertussis toxin (P TX) was from Porton Products (Dorset, UK); CdCl 2 (AnalaR grade) was from BDH Chemicals (Poole, UK); BaC l 2 and C sC l were from Aldrich (Milwaukee, W I). Nifedipine was prepared as a stock solution (10 mM) in ethanol and protected from light during storage and use.
RESULTS

Ca 2؉ channel current inhibition
We have reported previously that, in SCG neurons preinjected with 1.25 g/l P2Y 2 cRNA (together with GFP cRNA), the application of UTP produced a reversible inhibition of the Ca Filippov et al., 1997) . Because no significant inhibition was detected on applying 100 M UTP to neurons injected with GFP cRNA alone, this effect could be attributed entirely to the activation of newly expressed P2Y 2 receptors and not to the activation of any endogenous UTP-sensitive receptors that might have been present (see below).
Voltage dependence
Ca 2ϩ current inhibition in SCG neurons produced by activation of some endogenous receptors (see Hille, 1994) or by heterologously expressed mGluR2 receptors (Ikeda et al., 1995) is voltage-dependent-that is, it is reduced at depolarized commands (or by predepolarization; Grassi and Lux, 1989) and is accompanied by "kinetic slowing" resulting from time-dependent relief of block during the depolarizing command (Bean, 1989) . Figure 1 shows that the block produced by activating heterologously expressed P2Y 2 receptors shares this property. Thus, currentvoltage curves constructed by using either stepped ( Fig. 1 A,B) or ramped ( Fig. 1C ) commands showed a greater inhibition by UTP at negative potentials than at positive potentials (resulting in a positive shift of the current peak). For example, in Figure 1 A peak current inhibition was reduced from ϳ63% at 0 mV to ϳ26% at ϩ40 mV. Also, as shown in Figure 1 , B and D, current activation was slowed in the presence of UTP, such that inhibition was less at the end of the 40 msec command than at the beginning. Finally, inhibition was reduced (from 65.0 Ϯ 3.1 to 24.9 Ϯ 5.4%) and the slowing of current activation was abolished when the test command was preceded by a 20 msec depolarizing prepulse to ϩ120 mV (Fig. 1D ). Such effects have been interpreted to indicate that the activated G-protein (probably the ␤␥-subunit; Herlitze et al., 1996; Ikeda, 1996; Delmas et al., 1998a,b) interacts directly with the Ca 2ϩ channel protein to induce a gating shift (Dolphin, 1995; Jones and Elmslie, 1997) .
Pertussis toxin distinguishes two pathways for P2Y 2 -mediated Ca 2ϩ channel current inhibition
Voltage-dependent Ca 2ϩ current inhibition of the type illustrated in Figure 1 is usually (although not invariably; Ehrlich and Elmslie, 1995) associated with activation by the receptor of a G-protein of the Pertussis toxin-sensitive G i /G o family (Hille, 1994) . We tested whether this applied to expressed P2Y 2 receptors by overnight incubation of injected neurons with 0.5 g/ml Pertussis toxin (PTX). In cells preinjected with 1.25 g/l P2Y 2 cRNA, PTX substantially (ϳ61%) but incompletely reduced the inhibition produced by 10 M UTP (Fig. 2 A) . In contrast, in the same neurons the inhibition produced by 10 M norepinephrine (which is mediated primarily by G o ; Caulfield et al., 1994; Del- Voltage-dependent inhibition of C a 2ϩ channel currents by UTP in rat SCG neurons expressing heterologous P2Y 2 receptors. Neurons were preinjected with 1.25 g/l P2Y 2 cRNA. Records show leak-subtracted C a 2ϩ channel currents recorded at room temperature (20°C), using the whole-cell (ruptured patch) variant of the patch-clamp technique with 5 mM Ba 2ϩ as the charge carrier (I Ba ; see Materials and Methods). A, I Ba amplitude plotted against membrane voltage (I-V relationship) in the absence ( filled circles) and presence ( filled squares) of 100 M UTP. Currents were evoked by 10 mV incrementing test pulses, starting from a holding potential of Ϫ90 to ϩ40 mV; amplitudes were measured 10 msec from the onset of the test pulse. B, Superimposed currents from A at 0 and ϩ40 mV test potentials in the absence and presence of UTP. Note that the inhibition is less at ϩ40 than at 0 mV. C, Superimposed currents recorded with 750 msec depolarizing voltage ramps from Ϫ90 to ϩ 40 mV (see Materials and Methods) in the absence and presence of 100 M UTP. Note that the inhibition is less at more positive voltages. D, Superimposed currents (lower traces) recorded with a double-pulse voltage protocol (upper traces) in the absence and presence of 100 M UTP. The current was recorded first with a 40 msec test pulse to 0 mV; then, after a 2 sec interval, a 25 msec conditioning prepulse to ϩ120 mV was applied, followed 4 msec later by a second 40 msec test pulse to 0 mV. The bar chart at the bottom shows the mean percentage of current inhibition (measured after 10 msec at 0 mV command potential) by 100 M UTP before (Prep.0) and after (Prep.120) the ϩ120 mV prepulse. Error bars show SEM; n ϭ number of cells. Note that the inhibition is much less after the prepulse. Note also that the prepulse abolished the slowing of the current onset at 0 mV produced by UTP. mas et al., 1998a) was reduced by Ͼ90%, as previously reported (Beech et al., 1992; Chen and Schofield, 1993; C aulfield et al., 1994; Delmas et al., 1998a) , thus indicating the effectiveness of the PTX treatment. Nevertheless, because the initial inhibition produced by UTP exceeded that produced by norepinephrine, we were concerned that the substantial component of P TX-resistant inhibition might have resulted from overexpression (and aberrant coupling) of the P2Y 2 receptors. This appeared not to be the case, because P TX produced a comparable degree of attenuation (Ϫ54%) of the response to UTP in cells preinjected with 0.5 g/l P2Y 2 cRNA, although the initial inhibition produced by UTP (41.6 Ϯ 5.5%) was now less than that produced by norepinephrine (46.1 Ϯ 4.2%; Fig. 2 D) .
In contrast to the partial antagonism of overall inhibition, PTX pretreatment virtually eliminated the voltage dependence of P2Y 2 -mediated inhibition; the characteristic slowing of current activation by UTP (compare with Fig. 1 ) was no longer apparent after P TX treatment (Fig. 3A) , and the ϩ120 mV depolarizing prepulse did not reverse the inhibition significantly (Fig. 3B,C) . Thus, the P TX-insensitive component of block also appeared to be voltage-insensitive.
One possible explanation for the P TX-resistant voltageinsensitive component of inhibition is that it reflects the inhibition of an L -type current, rather than the N-type current (Hille, 1994) . This possibility is enhanced by previous observations that UTP inhibits both L -type and N-type currents in NG108-15 cells (Filippov and Brown, 1996) . To check this, we tested the effect of 2-10 M nifedipine on the response to UTP of P TX-pretreated SCG neurons preinjected with 1.25 g/l P2Y 2 cRNA. In agreement with previous observations on non-P TX-treated cells (Filippov et al., 1997) , nifedipine itself did not produce any significant inhibition of the current (Ϫ2.5 Ϯ 1.7%; n ϭ 13), nor did it affect the inhibitory action of UTP (Ϫnifedipine, Ϫ29.4 Ϯ 3.5%; ϩni-fedipine, Ϫ27.3 Ϯ 4.25%; n ϭ 6). Thus, the residual PTXinsensitive block is not attributable to the inhibition of L-type channels.
Coupling of P2Y 2 receptors to M-type K
؉ currents M-currents are sustained voltage-gated K ϩ currents that are activated when SCG neurons are depolarized above Ϫ70 mV (Constanti and Brown, 1981 ) (for review, see Brown, 1988) . They can be inhibited by activating endogenous M 1 -muscarinic acetylcholine receptors (Marrion et al., 1989; Bernheim et al., 1992) , angiotensin receptors (Shapiro et al., 1994) , or bradykinin receptors (Jones et al., 1995) -in all cases via PTX-insensitive G-proteins (probably G q ; see Caulfield et al., 1994; Jones et al., 1995) .
There is some evidence for the presence of endogenous P2Y receptors in intact SCGs [Connolly et al. (1993) ; Boehm et al. (1995) and personal communication; Connolly and Harrison (1995); Von Kugelgen et al. (1997) ]. However, we found that UTP did not affect the M-current significantly in the uninjected dissociated neurons that we have used, although some other nucleotides did (see below and Fig. 7A ). We therefore have tested whether the activation of heterologously expressed P2Y 2 receptors inhibits the M-current in these neurons, and, if so, how this compares with inhibition of Ca 2ϩ current. Figure 4 illustrates the effect of UTP on M-currents in cells preinjected with 1.25 g/l P2Y 2 cRNA. The cell was predepolarized to Ϫ20 mV to preactivate the M-current and then hyperpolarized in steps of Ϫ10 mV for 1 sec each to deactivate the current; deactivation is signaled by the inward tail currents, which reverse at E K (approximately Ϫ90 mV). UTP (10 M) clearly inhibited the M-current; this is indicated by (1) the inward shift in holding current at Ϫ20 mV (reflecting the reduction in outward K ϩ current), (2) reduced current responses to depolarizing steps (reduced conductance) and the loss of M-current deactivation tails, and (3) reduced outward rectification in the current-voltage curve positive to Ϫ70 mV, with no change in slope negative to Ϫ70 mV (indicating no change in "leak" current).
M-current inhibition was quantitated by using voltage ramps to obtain current-voltage curves (see Fig. 6 ) and then subtracting from the total outward current at Ϫ30 mV the extrapolated linear leak currents from potentials negative to Ϫ70 mV. UTP (10 M) inhibited the M-current by 60.8 Ϯ 9.6% (n ϭ 8) in neurons preinjected with 1.25 g/l P2Y 2 cRNA. As noted above, UTP had no significant effect at 100 M (0.6 Ϯ 0.4% inhibition) in five noninjected cells (Fig. 5A) . In four of these same cells the activation of the endogenous muscarinic acetylcholine receptors with 10 M oxotremorine-M (OxoM) inhibited the current by 55.4 Ϯ 11.4%, in accordance with previous observations (see Caulfield et al., 1994) , indicating that the endogenous transduction machinery was intact.
With the use of increasing concentrations of UTP, mean IC 50 values and extrapolated maximum inhibitions were 1.49 Ϯ 0.18 M and 48.0 Ϯ 1.2%, respectively, after 1.25 g/l P2Y 2 cRNA was injected, and 2.41 Ϯ 0.43 M and 43.2 Ϯ 1.9% after 0.5 g/l P2Y 2 cRNA was injected (Fig. 6 ). These IC 50 values are approximately three times higher than those determined for N-type Ca 2ϩ current inhibition (Filippov et al., 1997 ) (superimposed curves in Fig. 6 ). The lower apparent maximum inhibition with increasing UTP concentrations than those in Figure 5 may reflect some degree of desensitization (apparent as a slow partial recovery of M-current during prolonged application of UTP); the extent to which this affected IC 50 estimates is unclear.
In contrast to its effect on Ca 2ϩ current inhibition, PTX produced no significant attenuation of UTP-induced M-current inhibition (Fig. 5B) . Also, inhibition of M-current showed no Figure 2 . Pertussis toxin (PT X ) distinguishes two pathways for P2Y 2 -mediated Ca 2ϩ channel current inhibition. The bar charts show the mean inhibition of I Ba amplitude by 10 M UTP and by 10 M norepinephrine in neurons pretreated with P TX (0.5 g/ml, overnight; ϩPT X ) and in PTX-untreated neurons (Control ). Error bars show SEM; n ϭ number of cells. Neurons were injected with 1.25 g/l P2Y 2 cRNA ( A) or 0.5 g/l P2Y 2 cRNA ( B). Currents were recorded by stepping for 100 msec from Ϫ90 to 0 mV and measured 10 msec from the onset of the test pulse. Note that PTX pretreatment completely prevented the effect of norepinephrine, but not that of UTP.
clear voltage dependence in that neither the current-voltage curve nor the kinetics of the deactivation relaxations was altered appreciably in the presence of UTP.
We f urther tested the effects of several other nucleotides, using a standard concentration of 10 M (Fig. 7A) . The approximate order of activity was UTP Ն ATP Ͼ ITP Ͼ Ͼ GTP,UDP. This accords with their relative activities in inhibiting the Ca 2ϩ current in P2Y 2 -expressing SCG neurons (Fig. 7B ) (see Filippov et al., 1997) and also with stimulation of inositol phosphate production or intracellular C a 2ϩ elevation in other cells expressing cloned P2Y 2 receptors (L ustig et al., 1993; Chen et al., 1996; Nicholas et al., 1996) and in NG108-15 cells expressing the endogenous receptor (Lin et al., 1993) ; the strong activity of ITP and relatively weak activity of UDP (see below) are particularly noteworthy in this respect. The inhibitory activity of ADP was less than that of UTP and appeared to be less than that of ATP, but it was difficult to quantitate because ADP produced some inhibition of both M-and C a 2ϩ currents in control (GFP cRNAinjected) cells (Fig. 7, shaded columns) -possibly via a lowabundance endogenous P2Y 1 receptor. ATP also partly inhibited I K(M) in control cells; the other nucleotides tested (UTP, UDP, ITP, GTP) did not produce any significant effect on either Ca 2ϩ -or M-current in the cells preinjected with GFP cRNA alone. [It should be noted that, because the test concentration of UTP was near-maximal, the relative heights of the bars in Fig. 7 do not provide an accurate index of numerical potency ratios. For example, ADP was ϳ50 times less potent than UTP in inhibiting I C a when measured from f ull dose -response curves (Filippov et al., 1997) . Thus the dinucleotides ADP and UDP are likely to be at least one or two orders of magnitude less potent than UTP in inhibiting the M-current. Unfortunately, because of desensitiza- Figure 4 . Activation of heterologously expressed P2Y 2 receptors inhibits the M-type K ϩ current (M-current; I K(M) ) in rat SCG neurons. The neuron was injected 18 hr beforehand with 1.25 g/l P2Y 2 cRNA. M-current was recorded with a perforated patch electrode by predepolarizing the neuron to Ϫ20 mV and then deactivating the current with 1 sec hyperpolarizing steps in increments of 10 mV at 5 sec intervals, as shown in the current records. The graph shows the current amplitude at the end of each 1 sec step measured as change from zero current. Currents were recorded before ( filled squares; Control ) and after ( filled circles) the addition of 10 M UTP. Note that UTP produced an inward current at the holding potential of Ϫ20 mV, reduced the amplitude of the M-current deactivation tail currents during the hyperpolarizing steps, and reduced the outward rectification of the current-voltage curve positive to Ϫ70 mV. (The slight outward drift of the holding current in the presence of UTP reflects slow receptor desensitization.) Figure 3 . PTX pretreatment eliminates the voltage dependence of P2Y 2 -mediated Ca 2ϩ channel current inhibition. C ells were pretreated with 500 ng /ml P TX. Records in A show superimposed I Ba traces generated with the same double-pulse voltage protocol as in Figure 1 D in the absence and presence of 10 M UTP. The bar charts show the mean inhibition of I Ba by 10 M UTP before (Prep.0) and after (Prep.120) a ϩ120 mV prepulse in neurons injected with 1.25 g/l P2Y 2 cRNA ( B) and 0.5 g/l P2Y 2 cRNA ( C). Note that, after PTX treatment, UTP no longer slowed the recorded currents and that the prepulse no longer significantly reduced inhibition (compare with Fig. 1 ).
tion and slow recovery, it was not possible to construct full dose-response curves for the inhibitory action of the weaker analogs on the M-current.]
To check whether the effects of UDP and ADP in cRNA P2Y 2 preinjected cells arise from possible contamination of these nucleotides by UTP and ATP (see Nicholas et al., 1996) , we performed such tests by using purified UDP and ADP from Boehringer Mannheim (99% pure) immediately after their dissolution in the medium. In addition, we used samples of UDP and ADP pretreated for 1 hr with hexokinase (1 mM UDP or ADP incubated with 10 U/ml hexokinase plus 22 mM glucose at 37°C); this should convert any UTP and ATP that was present to their diphosphates (Nicholas et al., 1996) . The hexokinase pretreatment did not significantly reduce the inhibitory effects of 10 M UDP or ADP, and the pure UDP and ADP produced inhibitions within the range of those observed with the same nucleotides from Sigma.
Effects on excitability
The inhibition of M-type K ϩ currents and N-type C a 2ϩ currents through endogenous G-protein-coupled receptors increases the excitability of SCG neurons. This occurs because the M-current itself acts as a "braking" current on action potential discharges (see Brown, 1988) , and the entry of C a 2ϩ through N-type Ca 2ϩ channels opens C a 2ϩ -activated K ϩ channels and thereby induces a long-lasting afterhyperpolarization (AHP), which f urther limits subsequent spike activity [see Davies et al. (1996) and references therein]. Thus, the activation of expressed P2Y 2 receptors also might be expected to enhance spike activity. Figure 8 shows that this was the case. In Figure 8 A, the cells were challenged with long depolarizing or hyperpolarizing current injections from a preset potential of Ϫ60 mV at room temperature, at 20°C (Fig. 8 Aa) , and at 34°C (Fig. 8 Ab) . The long depolarizing current induced a brief burst of two to three spikes, followed by silence. The application of UTP had no effect on this spike discharge in control cells preinjected with GFP cRNA but greatly prolonged the discharge in cells preinjected with P2Y 2 cRNA. This effect of UTP was increased dramatically at 34°C ( Fig. 8 Ab) ; this occurs probably because M-current kinetics are faster at 34°C (Brown, 1988) , thereby exerting a faster and more effective "brake" on firing (see Cuevas et al., 1997) . UTP also increased the voltage response to hyperpolarizing current pulses (Fig. 8 Ab) , as expected after M-current inhibition (see . These effects closely resemble the effect of activating endogenous muscarinic receptors in SCG neurons (see Brown and Constanti, 1980) . Figure 8 B shows the effect of stimulating expressed P2Y 2 receptors on the Ca 2ϩ -activated afterhyperpolarization that follows an action potential: UTP abbreviated the afterhyperpolarization in a manner resembling the effect of stimulating endogenous ␣2-adrenergic receptors with norepinephrine (Horn and McAfee, 1980) , which results from the inhibition of the N-type Ca 2ϩ current (Galvan and Adams, 1982; Schofield, 1990) .
DISCUSSION
The principal points emerging from these and the preceding experiments (Filippov et al., 1997) are that the recombinant rat . Concentration dependence for UTP inhibition of M-current (solid lines) and N-type C a 2ϩ channel current (dashed lines) in cells preinjected with 1.25 g/l P2Y 2 cRNA (circles) or 0.5 g/l P2Y 2 cRNA (triangles). M-current was recorded by using a voltage ramp protocol (inset) and was measured at Ϫ30 mV (see Materials and Methods). The points show the mean Ϯ SEM of measurements in three to four cells; concentrations were added cumulatively, with 1 min exposure times. Curves were fit to pooled data points, using Origin 4.1 software to the Hill equation: y ϭ y max ⅐ x nH /(x nH ϩ K nH ), where y ϭ the observed percentage of inhibition, y max ϭ extrapolated maximal percentage of inhibition, x ϭ nucleotide concentration (M), K ϭ IC 50 (M), and n H ϭ the Hill coefficient. Values of constants (mean Ϯ SEM) for M-current inhibition were y max ϭ 48.0 Ϯ 1.20%, K ϭ 1.49 Ϯ 0.14 M, n H ϭ 1.29 Ϯ 0.14 for neurons injected with 1.25 g/l P2Y 2 cRNA; and y max ϭ 43.2 Ϯ 1.95%, K ϭ 2.41 Ϯ 0.43 M, n H ϭ 0.88 Ϯ 0.11 for neurons injected with 0.5 g/l P2Y 2 cRNA. Data for C a 2ϩ channel current inhibition (dashed lines) are taken from Filippov et al. (1997) P2Y 2 receptor can couple with near-equal facility to two quite different neural ion channels-the N-type voltage-gated Ca 2ϩ channel and the M-type K ϩ channel -when expressed in rat SCG neurons and that this involves the intermediation of at least two different G-proteins. Dual coupling to these particular channels by one species of G-protein-linked receptor is unusual (see below) and suggests that the P2Y 2 receptor can have a potentially broader range of effects on neurons than many other neurotransmitter receptors.
This apparent cross-talk is unlikely to be an artifact of receptor overexpression, for two reasons. First, it was preserved after injections of two different amounts of the receptor cRNA, such that, at the lower level (0.5 g/l), the maximum response to UTP was less than that obtained on stimulating endogenous adrenergic and muscarinic receptors. Thus, although (in the absence of appropriate antibodies) we have not been able to measure the number of receptors expressed, they are unlikely to be "excessive" in comparison to other endogenous serpentine receptors in these cells. Second, the IC 50 values for UTP observed in the present experiments (0.5-0.9 M for Ca 2ϩ current inhibition and 1.5-2.4 M for M-current inhibition) are not dissimilar to those observed for UTP to elevate intracellular [Ca 2ϩ ] [1.1 M, Lustig et al. (1993) ; ϳ1.1 M, Parr et al. (1994) ; 0.2 M, Chen et al. (1996) ] or to stimulate inositol phosphate production (ϳ0.1 M; Nicholas et al., 1996) when applied to recombinant P2Y 2 receptors expressed in other cell lines. (IC 50 values likely will vary from one expression system to another, depending on the level of receptor expression, as indicated by the dose-response curves in Fig. 6 .) More pertinently, perhaps, the present IC 50 values also and hyperpolarizing (Ϫ0.2 nA) current pulses from P2Y 2 cRNA (1.25 g/l) preinjected neuron before and during the application of UTP at 34°C. B, Afterhyperpolarization (AHP) that followed an action potential evoked by a brief depolarizing current pulse (1 nA, 1 msec) recorded from a P2Y 2 cRNA (1.25 g/l) preinjected neuron before and during the application of UTP at 34°C. accord with those that follow the stimulation of the endogenous P2Y 2 receptor in NG108-15 cells [ϳ3 M for inositol phosphate production (Lin, 1994) ; 0.8 M for M-like current inhibition (Filippov et al., 1994) ; 2.8 M for N-type C a 2ϩ current inhibition (Filippov and Brown, 1996) ]. The agreement between the results obtained on stimulating the endogenous receptors in this neural cell line and the exogenously expressed receptors in SCG neurons strongly suggests that the effects we see are likely to be a general phenomenon, applicable in other cells in which the same receptor might be expressed.
These divergent responses start at the level of the G-protein. M-current inhibition was insensitive to P TX; although we have not positively identified the species of P TX-resistant G-protein(s) responsible, previous experiments that used site-directed antibodies on the analogous effects of muscarinic agonists (Caulfield et al., 1994) and bradykinin (Jones et al., 1995) suggest that it is most likely G q and /or G 11 (principally G q ; Haley et al., 1997) . In contrast, C a 2ϩ current inhibition is mediated by at least two G-proteins: a P TX-sensitive G-protein, responsible for the gating shift and for ϳ60% of the peak inhibition measured at 0 mV, and a PTX-insensitive G-protein responsible for the residual voltageinsensitive component of inhibition. By analogy with the voltagedependent effects of norepinephrine, somatostatin, and M 4 muscarinic stimulation, the former (P TX-sensitive) G-protein is probably G oA (C aulfield et al., 1994; Delmas et al., 1998a,b) , and the gating shift probably results from the interaction of the dissociated free ␤␥-subunits with the C a 2ϩ channel protein (see Herlitze et al., 1996; Ikeda, 1996; Delmas et al., 1998a,b) . The PTX-insensitive G-protein responsible for the voltage-insensitive component of C a 2ϩ current inhibition could well be the same as that (G q ?) postulated to cause M-current inhibition, because M 1 muscarinic acetylcholine receptor stimulation produces the same dual-effector response via G q (Delmas et al., 1998b) .
In effect, therefore, stimulating the P2Y 2 receptor imitates the combined effects of stimulating two separate endogenous muscarinic acetylcholine receptors, the M 1 and the M 4 receptors (see Hille, 1994) . This is summarized in Figure 9 ; at a minimum, it requires parallel coupling of the P2Y 2 receptor to two G-proteins: G q (leading to inhibition of the M-current and voltageindependent inhibition of the C a 2ϩ current) and G o (producing a gating shift of the C a 2ϩ channels). There are other instances of "promiscuity" in receptor/Gprotein coupling (see Milligan, 1997) . This can result in effects on more than one ion channel -for example, the inhibition of Ca 2ϩ currents and the activation of inward rectifier (K ir ) K ϩ currents (Surprenant et al., 1992) . However, dual coupling to C a 2ϩ N and K ϩ M channels through two G-proteins by a single, defined receptor is more unusual. Thus, although many transmitters can, collectively, modulate C a 2ϩ currents or M-currents in SCG neurons in a manner similar to that produced by P2Y 2 receptors (see Hille, 1994) , this usually involves the activation of separate receptors, each coupled to a different G-protein. As indicated already, muscarinic acetylcholine agonists can produce the same dual response as UTP, but to do so they have to activate two different molecular species of muscarinic receptor; activation of G o (and the C a 2ϩ channel gating shift) requires M 4 receptors, whereas activation of G q (and consequential voltage-independent inhibition of M-current and C a 2ϩ current) requires M 1 receptors (see Beech et al., 1992; Delmas et al., 1998b) . This also applies to other heterologous receptors expressed by this method. Thus, there is negligible cross-talk between heterologous mGluR1a and mGluR2 receptors expressed from cRNA injections; the former inhibit M-currents via a PTX-insensitive G-protein with insignificant effect on the Ca 2ϩ current, whereas mGluR2 receptors inhibit Ca 2ϩ currents entirely through a PTX-sensitive G-protein without any effect on M-currents (Ikeda et al., 1995) . Likewise, heterologously expressed cannabinoid receptors selectively inhibit Ca 2ϩ currents through a PTX-sensitive G-protein (Pan et al., 1996) . The closest analogy is provided by the action of angiotensin, which also couples through two G-proteins (PTXsensitive and insensitive) to inhibit Ca 2ϩ and M-currents (Shapiro et al., 1994) ; however, it has not yet been established whether both coupling routes are activated by the same or different molecular species of angiotensin receptor.
Physiological significance
From a functional viewpoint, the net effect of stimulating expressed P2Y 2 receptors in SCG neurons is to increase their excitability (see Fig. 8 A) . This is the expected result of inhibiting the M-current and the N-type Ca 2ϩ current, because reducing the latter will decrease the Ca 2ϩ -dependent K ϩ current and abbreviate the spike afterhyperpolarization (as shown in Fig.  8 B) , and K M and K C a currents act as synergistic braking currents on spike discharge (see Jones and Adams, 1987) . This is essentially a postsynaptic response; it mimics the natural postsynaptic effect of activating the endogenous muscarinic receptors by synaptically released acetylcholine in SCG neurons (see Brown, 1988) , so it would provide a mechanism for slow postsynaptic excitation by a nucleotide transmitter. Although no such nucleotide-mediated synaptic responses have been reported yet, comparable excitatory effects of e xogenous UTP and ATP have been described in, for example, frog sympathetic (Siggins et al., 1977; Adams et al., 1982; Akasu et al., 1983; L opez and Adams, 1989) , frog sensory (Tokimasa and Akasu, 1990) , and rat intracardiac (Cuevas et al., 1997) ganglion cells. However, the species of P2Y receptor responsible for these effects has not been determined, nor is there yet any direct evidence for equivalent effects on central neurons.
On the other hand, if endogenous P2Y 2 receptors were located presynapticall y, then the most likely effect of their stimulation would be to reduce transmitter release via the inhibition of the N-type Ca 2ϩ current, in the same manner as stimulating endogenous presynaptic adrenergic or muscarinic receptors in SCG neurons (Boehm and Huck, 1996; Koh and Hille, 1997) . This would provide a mechanism for autoinhibition in nucleotidereleasing nerve terminals. There is some evidence for P2Y-mediated autoinhibition in peripheral sympathetic nerves (Fuder and Muth, 1993) and chromaffin cells (Currie and Fox, 1996) ; also, P2Y-mediated inhibition of norepinephrine release from isolated brain tissue by exogenous nucleotides has been reported (Von Kugelgen et al., 1994) , but the identity of these receptors has not yet been established.
As pointed out in the introductory remarks, there is now direct evidence for the synaptic release of ATP in the brain and the consequent activation of postsynaptic P2X receptors (Edwards and Gibb, 1993) . Although there is, as yet, no evidence for the synaptic release of UTP, the latter nucleotide can be released from cells by other mechanisms (Lazarowski et al., 1997) . Because mRNA for the P2Y 2 receptor is expressed in the brain , were this receptor to be activated by either of these endogenously released nucleotides, its dual coupling would provide scope for some unusually divergent effects on neural signaling.
